Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The NMDA receptor complex

B Scatton1

  • 1Synthélabo Recherche, Bagneux, France.

Fundamental & Clinical Pharmacology
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

The N-methyl-D-aspartate (NMDA) receptor is crucial for synaptic plasticity and neuronal function. Its overstimulation is linked to ischemic brain injury, highlighting the importance of understanding its structure and regulation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of the beta3-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: relevance to its antidepressant/anxiolytic-like profile.

Neuroscience·2008
Same author

Peripheral type benzodiazepine binding sites as a tool for the detection and quantification of CNS injury.

Current protocols in neuroscience·2008
Same author

New perspectives for the treatment of disorders of sleep and arousal.

Annales pharmaceutiques francaises·2007
Same author

SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit.

Psychopharmacology·2005
Same author

SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.

The Journal of pharmacology and experimental therapeutics·2004
Same author

SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation.

The Journal of pharmacology and experimental therapeutics·2003
Same journal

Glucagon-Like Peptide-1 Receptor Agonists in Cocaine Use Disorder: Clinical Observations and Underlying Mechanisms.

Fundamental & clinical pharmacology·2026
Same journal

TAAR1-Associated Trace Amines for Cutaneous Nociceptive Blockade in Rats.

Fundamental & clinical pharmacology·2026
Same journal

Synergistic Cardioprotection of Colchicine and Hyperbaric Oxygen Therapy in a Rat Model of Remote Ischemia-Reperfusion Injury.

Fundamental & clinical pharmacology·2026
Same journal

Probucol Exerts Anticancer Effects on SW480 Human Colorectal Cancer Cells via Modulation of Apoptosis- and Angiogenesis-Related Proteins.

Fundamental & clinical pharmacology·2026
Same journal

Nebivolol Protects the Thoracic and Abdominal Aorta and Their Perivascular Adipose Tissue From the Differential Detrimental Effects of Obesity.

Fundamental & clinical pharmacology·2026
Same journal

Monitoring of Clinics That Use Direct-to-Consumer Advertising for Off-Label Ketamine in the New York Metropolitan Area: A Cross-Sectional Systematic Web Search.

Fundamental & clinical pharmacology·2026
See all related articles

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Synaptic responses in the CNS involve glutamate and aspartate receptors, including the ionotropic NMDA receptor.
  • The NMDA receptor plays roles in neuronal activity, synaptic efficacy, plasticity, and is implicated in ischemic brain injury.

Purpose of the Study:

  • To elucidate the molecular structure and regulatory mechanisms of the NMDA receptor.
  • To understand the molecular basis of NMDA receptor-mediated neurotoxicity.

Main Methods:

  • Review of existing literature on NMDA receptor structure, function, and regulation.
  • Analysis of molecular cloning data identifying NMDA receptor subunits (NMDA-R1, NMDA-R2A-D).

Main Results:

Related Experiment Videos

  • The NMDA receptor possesses a cationic channel permeable to Ca2+, Na+, and K+, with binding sites for Mg2+, anesthetics, glycine, Zn2+, and polyamines.
  • NMDA receptor function is modulated by voltage, pH, redox state, and endogenous substances like NO and arachidonic acid.
  • Distinct NMDA receptor subtypes are formed by heteromeric assembly of NMDA-R1 and NMDA-R2 subunits.

    • Conclusions:

    • Understanding the molecular structure of the NMDA receptor is key to deciphering its regulatory features.
    • Knowledge of NMDA receptor structure will illuminate the molecular mechanisms underlying neurotoxicity and potential therapeutic targets.